Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial.
Authors: Luis SA; Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA., Klein AL; Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine Heart, Vascular and Thoracic Institute, Cleveland Clinic Cleveland OH USA., Cremer PC; Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine Heart, Vascular and Thoracic Institute, Cleveland Clinic Cleveland OH USA.; Departments of Medicine and Radiology, and Multimodality Cardiac Imaging and Clinical Trials Unit Bluhm Cardiovascular Institute, Northwestern University Chicago IL USA., Abbate A; Berne Cardiovascular Research Center University of Virginia Charlottesville VA USA., Salik JR; Cardiology Division Massachusetts General Hospital, Harvard Medical School Boston MA USA., Thomas GK; Virginia Commonwealth University Health System Richmond VA USA., Haider SW; Pericardial Disease Program MedStar Georgetown University Hospital Washington DC USA., Hagerty TE; University of Vermont Medical Center, Larner College of Medicine Burlington VT USA., Lin D; Minneapolis Heart Institute, Abbott Northwestern Hospital/Allina Health Minneapolis MN USA., Waggoner TE; US Heart & Vascular, Tucson Medical Center Tucson AZ USA., Nicholls SJ; Victorian Heart Institute Monash University Melbourne VIC Australia., Kirwan BA; SOCAR Research SA Nyon Switzerland.; Faculty of Epidemiology and Public Health London School of Hygiene and Tropical Medicine London UK., Narine KAD; Cardiol Therapeutics Inc. Oakville ON Canada., Parker AB; Cardiol Therapeutics Inc. Oakville ON Canada., Hamer A; Cardiol Therapeutics Inc. Oakville ON Canada.
Source: Journal of the American Heart Association [J Am Heart Assoc] 2026 Jul 21; Vol. 15 (14), pp. e047605. Date of Electronic Publication: 2026 Jul 10.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2047-9980
DOI:10.1161/JAHA.125.047605